Deschlorobenzoyl Indomethacin

Deschlorobenzoyl Indomethacin

SCHEMBL454792

COc1ccc2[nH]c(C)c(CC(=O)O)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 1.00
KDM4E B2RXH2 10/20 0.69
ALDH1A1 P00352 9/20 0.69
MAPT P10636 5/20 0.69
GAA P10253 4/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
MTNR1A P48039 2/20 0.63
MTNR1B P49286 2/20 0.63
HTR1D P28221 2/20 0.62
HTR6 P50406 2/20 0.62
CASP1 P29466 1/20 0.60
CASP7 P55210 1/20 0.60
PTGS1 P23219 1/20 0.60
PTGS2 P35354 1/20 0.60
HTR1A P08908 1/20 0.59
SLC6A2 P23975 1/20 0.59
HTR1E P28566 1/20 0.59
HTR7 P34969 1/20 0.59
HTR5A P47898 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205891 0.89 AKR1C2 (0.80) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL6290446 0.89 AKR1C2 (0.80) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL6825151 0.87 AKR1C2 (0.78) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL8681515 0.87 AKR1C2 (0.78) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL4245648 0.87 AKR1C2 (0.78) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL30604527 0.87 AKR1C2 (0.78) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL852717 0.86 AKR1C2 (0.76) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL8270880 0.85 AKR1C2 (0.74) AKR1C2KDM4EALDH1A1MAPTGAA
SCHEMBL10165841 0.85 AKR1C2 (0.74) AKR1C2KDM4EALDH1A1MAPTGAA
Deboxamet SCHEMBL186946 0.85 AKR1C2 (0.74) AKR1C2KDM4EALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122005550-A AHR ligand 5-methoxy-2 methyl-3-indoleacetic acid and application thereof 华中农业大学 2026-05-12 CN claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
CN-118880404-A Electrotinning solution for photovoltaic 江苏艾森半导体材料股份有限公司 2024-11-01 CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-117867608-A Neutral matte pure tin electroplating solution and preparation method thereof 成都开华化工研究所 2024-04-12 CN claimed
CN-116514701-A Indolic acid derivative for relieving colonitis and application thereof 华中农业大学 2023-08-01 CN claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 US claimed
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES Indiana University Research and Technology Corpora tion (US) 2016-06-23 US claimed
US-9217012-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-12-22 US claimed
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) 2012-04-12 US claimed
EP-0990047-A2 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID MOLECULES UTILIZING SIZING TECHNIQUES Rapigene, Inc. (US) 2000-04-05 EP claimed
US-6027890-A DETECTING LIGAND BINDING BY INCUBATING TAGGED MEMBERS WITH BIOLOGICAL SAMPLE, SEPARATING BOUND FROM UNBOUND MEMBERS, CLEAVING TAG, THEN DETECTING BY NON-FLUORESCENT SPECTROSCOPY OR POTENTIOMETRY RAPIGENE, INC. (US) 2000-02-22 US claimed
EP-0962464-A2 Methods and compositions for detecting binding of ligand pair using non-fluorescent label Rapigene, Inc. (US) 1999-12-08 EP claimed
WO-1999005319-A9 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE INC (US) 1999-06-17 WO claimed
WO-1999005319-A2 METHODS AND COMPOUNDS FOR ANALYZING NUCLEIC ACIDS BY MASS SPECTROMETRY RAPIGENE, INC. (US) 1999-02-04 WO claimed
EP-0868535-A2 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES Rapigene, Inc. (US) 1998-10-07 EP claimed
EP-0850320-A2 METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL DARWIN MOLECULAR CORPORATION (US) 1998-07-01 EP claimed
WO-1997027331-A9 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES 1997-10-09 WO claimed
WO-1997027331-A2 METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES RAPIGENE, INC. (US) 1997-07-31 WO claimed
WO-1997027327-A2 METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL RAPIGENE, INC. (US) 1997-07-31 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS AKR1C2 3993/4885KDM4E 2134/4885ALDH1A1 3087/4885
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS AKR1C2 3993/4885KDM4E 2134/4885ALDH1A1 3087/4885
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS AKR1C2 3993/4885KDM4E 2134/4885ALDH1A1 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.